Antiphospholipid antibody–associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone - 12/09/11
Abstract |
OBJECTIVE: The purpose of this study was to compare the use of low-dose aspirin alone with heparin and low-dose aspirin in the treatment of the antiphospholipid antibody syndrome. STUDY DESIGN: A prospective, single-center trial included 50 patients who were alternately assigned to treatment. Each patient had at least three consecutive spontaneous pregnancy losses, positive antiphospholipid antibodies on two occasions, and a complete evaluation. Data were compared by χ2 analysis and Fisher's exact test. RESULTS: Viable infants were delivered of 11 of 25 (44%) women treated with aspirin and 20 of 25 (80%) women treated with heparin and aspirin (p < 0.05). There were no significant differences between the low-dose aspirin and the heparin plus low-dose aspirin groups with respect to gestational age at delivery (37.8 ± 2.1 vs 37.2 ± 3.4 weeks), number of cesarean sections (18% vs 20%), or complications. CONCLUSION: Heparin plus low-dose aspirin provides a significantly better pregnancy outcome than low-dose aspirin alone does for antiphospholipid antibody–associated recurrent pregnancy loss. (AM J OBSTET GYNECOL 1996;174:1584-9.)
Le texte complet de cet article est disponible en PDF.Keywords : Recurrent pregnancy loss, antiphospholipid antibodies, heparin, low-dose aspirin
Plan
| ☆ | From the Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center at Dallas. |
| ☆☆ | Reprint requests: William H. Kutteh, MD, PhD, Division of Reproductive Immunology, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-9032. |
| ★ | 0002-9378/96 $5.00 + 0 6/1/69803 |
Vol 174 - N° 5
P. 1584-1589 - mai 1996 Retour au numéro
Article précédent
- Maternal concentrations and fetal-maternal concentration differences of plasma amino acids in normal and intrauterine growth-restricted pregnancies
- Irene Cetin, Stefania Ronzoni, Anna Maria Marconi, Giuseppe Perugino, Carlo Corbetta, Frederick C. Battaglia, Giorgio Pardi
- The pharmacokinetics of oxytocin as they apply to labor induction
- Rhonda L. Perry, Andrew J. Satin, William H. Barth, Sandra Valtier, John T. Cody, Gary D.V. Hankins, The opinions contained herein are those of the authors and are not to be construed as official or as reflecting the views of the U.S. Air Force or the Department of Defense.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?